ICYMI: New resource catalogs biopharmaceutical industry lessons learned from COVID-19
Since the start of the pandemic, America ’s biopharmaceutical companies haveworked around the clock to research, develop and manufacture treatments and vaccines to fight COVID-19. We ’ve made unprecedented progress with having delivered over 12 billion vaccines globally with another 20 billion expected in 2022.
Source: The Catalyst - Category: Pharmaceuticals Authors: Gabby Migliara Tags: Research and Development PDUFA Coronavirus Antimicrobial Resistance Source Type: news
More News: Antimicrobial Resistance | Coronavirus | Covid Vaccine | COVID-19 | Lessons | Pandemics | Pharmaceuticals | Vaccines